Radioisotope Therapy | Community Health

Radioisotope therapy, also known as unsealed source radiotherapy, is a type of cancer treatment that uses radioactive isotopes to target and destroy malignant cells. This approach has been used to treat various types of cancer, including thyroid cancer, prostate cancer, and lymphoma. According to the National Cancer Institute, over 100,000 patients in the United States receive radioisotope therapy each year. The therapy works by injecting or ingesting a radioactive isotope, which then accumulates in the tumor cells, delivering a high dose of radiation to the cancer while minimizing damage to surrounding healthy tissue. With a success rate of up to 90% in some cases, radioisotope therapy has become a valuable tool in the fight against cancer. As research continues to advance, new isotopes and delivery methods are being developed, offering hope for improved treatment outcomes and increased patient survival rates. For example, a study published in the Journal of Nuclear Medicine found that radioisotope therapy can improve survival rates by up to 30% in patients with advanced prostate cancer. The American Cancer Society and the Society of Nuclear Medicine and Molecular Imaging are prominent organizations that provide information and support for patients undergoing radioisotope therapy.